Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.
about
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Thyroid Autoimmunity.Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study.Reply to Poddighe.Association between Human Papilloma Virus (HPV) vaccination and risk of Multiple Sclerosis: A systematic review.HPV vaccine and autoimmune diseases: systematic review and meta-analysis of the literature
P2860
Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of new onset autoimmune d ...... vaccine in the United Kingdom.
@en
Risk of new onset autoimmune d ...... vaccine in the United Kingdom.
@nl
type
label
Risk of new onset autoimmune d ...... vaccine in the United Kingdom.
@en
Risk of new onset autoimmune d ...... vaccine in the United Kingdom.
@nl
prefLabel
Risk of new onset autoimmune d ...... vaccine in the United Kingdom.
@en
Risk of new onset autoimmune d ...... vaccine in the United Kingdom.
@nl
P2093
P2860
P1476
Risk of new onset autoimmune d ...... vaccine in the United Kingdom
@en
P2093
Anke L Stuurman
Corinne Willame
Dominique Rosillon
Eveline M Bunge
Hilde Vroling
Julia Zima
Manel Pladevall-Vila
Maria-Genalin Angelo
Rachael Boggon
P2860
P304
P356
10.1080/21645515.2016.1199308
P577
2016-07-18T00:00:00Z